Sen. Gregg Requests HHS Report On Pediatric Vaccine Stockpile
This article was originally published in The Pink Sheet Daily
Executive Summary
A revenue recognition issue is causing the stockpile to shrink, the Budget Committee chairman tells HHS. The “overdue” report, which was called for in the fiscal year 2005 appropriations legislation, should address administrative or legislative solutions, he says.
You may also be interested in...
SEC Seeks Vaccine Manufacturer Input On Pediatric Stockpile Accounting
Securities & Exchange Commission regulations on revenue recognition are preventing childhood vaccine manufacturers from selling product to a government stockpile. Rep. Waxman declares support for a special exemption for vaccine makers.
Endo’s Lidoderm Mailings Draw FDA Warning Letter For Unsubstantiated Claims
FDA asks Endo to disseminate “corrective messages” to doctors who received the violative promotional materials, which the agency says omit risk information and contain unsubstantiated effectiveness claims.